Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azelastine + fluticasone nasal spray vs Dymista in allergic rhinitis
CTR20190189Phase 3Completed
- Sponsor
- Changfeng Pharmaceutical
- Start
- Feb 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate in allergic rhinitis (AR), sponsored by Changfeng Pharmaceutical. Started Feb 2019; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on CTR20190189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190189.